Investigating the Molecular Mechanisms of Isocitrate Dehydrogenase 1: Biochemical and Cellular Approaches

Brittany Conley
Department: Department of Chemistry and Biochemistry
Program: M.S. in Chemistry
Date: Friday, September 18, 2026
Time: 10:00 a.m.
Location: Bioscience Center Gold Auditorium
Zoom: https://SDSU.zoom.us/j/87101764064
Committee Members
Dr. Christal D. Sohl, Chair (SDSU)
Dr. Carrie House (SDSU)
Dr. Rees Garmann (SDSU)
Dr. Navtej Toor (UC San Diego)
Dr. Brian Zid (UC San Diego)
Abstract
Isocitrate dehydrogenase 1 (IDH1) is a metabolic enzyme that supports cellular metabolism and lipid biosynthesis by catalyzing the oxidative decarboxylation of isocitrate to α-ketoglutarate (αKG). Cancer-associated mutations at residue R132 confer a neomorphic activity in which αKG is reduced to the oncometabolite D-2-hydroxyglutarate (D2HG), contributing to epigenetic dysregulation and tumorigenesis. Although the mechanism of wild-type IDH1 catalysis has been extensively studied and residues supporting this reaction have been well characterized, the active-site residues that enable neomorphic catalysis remain incompletely understood.
IDH1 also localizes to peroxisomes, organelles that coordinate essential pathways in lipid metabolism and redox homeostasis. However, the metabolic function of IDH1 within this organelle has not been established. This dissertation examines two complementary areas of IDH1 research: the critical residues contributing to neomorphic catalysis and the cellular significance of IDH1 localization. Through biochemical and cellular analysis, this work identifies distinct contributions of active-site residues to IDH1 catalysis, explores the cellular consequences of catalytically diverse tumor-associated mutants, and establishes a platform for investigating the role of peroxisomal IDH1.
